The PennZone

  • Home
  • Entertainment
  • Music
  • Marketing
  • Non-profit
  • Books
  • Education
  • Automotive
  • Roohid Parast

The Advocate Selected to Participate in Reuters Pharma & Patients 2022
The PennZone/10206754

Trending...
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Leading PDR Training Courses in Canada: Learn Paintless Dent Repair with PDR Academy & Tint Academy
  • GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
Reuters Pharma & Patients Conference 2022 The Advocate, working together with patient advocacy, professional associations/societies and pharmaceutical companies, hand-in-hand. (PRNewsfoto/The Advocate: Supporting the Patient Voice)
The Advocate Set To Detail of Pharma Manufacturers Work with Them to Manage Internal Leaders to Drive Change

WEST CHESTER, Pa., Oct. 31, 2022 /PRNewswire/ -- The Advocate: Supporting the Patient Voice is proud to announce it's Editor-in-Chief & Head of Advocacy Engagement, Matt Toresco, has been asked to speak at the Reuters Pharma and Patients Conference 2022. This year's conference is dedicated to both the clinical and commercial ends of the pharmaceutical manufacturer, to challenge the manufacturer to engage in new ways with patient advocates and patients to drive systemic change.

"I am proud to represent The Advocate and patient voices to the audience at Reuters in The Brooks Group's backyard of Philadelphia, from November 8th and 9th," Matt noted. "This [Reuters] opportunity allows us to tell the story of our partners and how they have used our data sets year over year to identify opportunities to better engage with patients and make true paradigm shifts within their organization." Matt was truly choked up when he noted, "It's humbling to have had the opportunity to hear these stories from our partners, true partners that have stuck with me through my own medical challenges over the last few months." He confined, "but we feel even more empowered to add more customers to continue to drive true outcomes for patients while laying out some key issues we see evolving over the last 7 years leaving patients in difficult spots."

More on The PennZone
  • Philadelphia's Girls Anthem to Host The Locker Room Experience Pop-Up for Young Women
  • Flexible Plan Investments Names Carl Resnick President
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska

You can find out more about the Reuters Pharma & Patients 2022 Conference taking place at the Old City Marriott in Philadelphia, November 8th & 9th at the conference's website at:  Reuters Patient & Pharma USA 2022

You can also reach out directly to Matt and the team at The Advocate through their website at https://theadvocatepatientvoice.com, on twitter at @The_Advocate_PV, or through email at [email protected].

SOURCE The Advocate: Supporting the Patient Voice
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
  • San Diego Attorney Anthony Z. Vargas Narrows Practice to Employment Law, Representing Employees Only
  • Solid Earth Introduces RealtyID, a Universal Identity Spine for the Real Estate Industry
  • GGILabs Expands Local SEO Services to Help Businesses Compete in AI-Driven Search
  • Sara Viteri, Turnstone Creative Senior Producer, Named to Lehigh Valley Business' Forty Under 40
  • Boyertown Mechanic Travels to Nashville to Learn How AI Is Changing Auto Repair
  • Colonial Nissan Earns Capital One Top Performing Dealership Award
  • BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
  • Logistics Expert Asks A Question Biology Has Overlooked: How Evolution Assembles Coordinated Novelty
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
  • Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
  • Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
  • DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
  • Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
  • Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
  • Philly Tailgates Announces Full 2026 Eagles Season Schedule, Opening With Back-to-back Events
  • The Golden Jazz Fest Shuttle Returns for 2026
  • KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night
  • Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 358
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
  • Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
  • New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
  • Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
  • Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
  • CodesClue: A Trusted AI-Based Software Development Company for Global Businesses
  • What's New in Hokkaido, Autumn 2026

Similar on PennZone

  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Slotozilla Reports Strong Growth in Q2 2026
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
  • Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
  • DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
  • Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
  • 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
  • Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us